NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹541 Cr | ₹316 Cr | ₹374 Cr | ₹362 Cr | ₹234 Cr |
What is the latest Sundry Debtors ratio of NEULAND LABORATORIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹541 Cr |
| Mar2025 | ₹316 Cr |
| Mar2024 | ₹374 Cr |
| Mar2023 | ₹362 Cr |
| Mar2022 | ₹234 Cr |
How is Sundry Debtors of NEULAND LABORATORIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹541 Cr | 71.47 | |
| Mar2025 | ₹316 Cr | -15.48 | |
| Mar2024 | ₹374 Cr | 3.25 | |
| Mar2023 | ₹362 Cr | 54.39 | |
| Mar2022 | ₹234 Cr | - | |
Compare Sundry Debtors of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹29,378.2 Cr | 15% | 20.8% | 69.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,471.0 Cr | -0.5% | 0.8% | 19% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,631.0 Cr | 2.2% | 23.1% | 27.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,157.0 Cr | -2.6% | -1.6% | 36% | Stock Analytics | |
| CIPLA | ₹118,108.0 Cr | 0.8% | 2.5% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,578.0 Cr | 2.6% | -2.4% | -5.6% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 15% |
20.8% |
69.8% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses